Literature DB >> 11549716

Secretin facilitates GABA transmission in the cerebellum.

W H Yung1, P S Leung, S S Ng, J Zhang, S C Chan, B K Chow.   

Abstract

Secretin was the first hormone discovered in human history, and yet, its function as a neuropeptide has been overlooked in the past. The recent discovery of the potential use of secretin in treating autistic patients, together with the conflicting reports on its effectiveness, urges an in-depth investigation of this issue. We show here that in the rat cerebellar cortex, mRNAs encoding secretin are localized in the Purkinje cells, whereas those of its receptor are found in both Purkinje cells and GABAergic interneurons. Immunoreactivity for secretin is localized in the soma and dendrites of Purkinje cells. In addition, secretin facilitates evoked, spontaneous, and miniature IPSCs recorded from Purkinje cells. We propose that secretin is released from the somatodendritic region of Purkinje cells and serves as a retrograde messenger modulating GABAergic afferent activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549716      PMCID: PMC6763004     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  39 in total

1.  Secretin and autism: a two-part clinical investigation.

Authors:  M G Chez; C P Buchanan; B T Bagan; M S Hammer; K S McCarthy; I Ovrutskaya; C V Nowinski; Z S Cohen
Journal:  J Autism Dev Disord       Date:  2000-04

Review 2.  The regulation of quantal size.

Authors:  W Van der Kloot
Journal:  Prog Neurobiol       Date:  1991       Impact factor: 11.685

Review 3.  Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors.

Authors:  C D Ulrich; M Holtmann; L J Miller
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

4.  Heterogeneity of release probability, facilitation, and depletion at central synapses.

Authors:  L E Dobrunz; C F Stevens
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

5.  Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.

Authors:  A D Sandler; K A Sutton; J DeWeese; M A Girardi; V Sheppard; J W Bodfish
Journal:  N Engl J Med       Date:  1999-12-09       Impact factor: 91.245

Review 6.  Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism.

Authors:  E Courchesne
Journal:  Curr Opin Neurobiol       Date:  1997-04       Impact factor: 6.627

7.  Genome-wide scan for autism susceptibility genes. Paris Autism Research International Sibpair Study.

Authors:  A Philippe; M Martinez; M Guilloud-Bataille; C Gillberg; M Råstam; E Sponheim; M Coleman; M Zappella; H Aschauer; L Van Maldergem; C Penet; J Feingold; A Brice; M Leboyer; L van Malldergerme
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

8.  Inhibitory synaptic currents in stellate cells of rat cerebellar slices.

Authors:  I Llano; H M Gerschenfeld
Journal:  J Physiol       Date:  1993-08       Impact factor: 5.182

9.  Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells.

Authors:  D van Calker; M Müller; B Hamprecht
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

10.  Axons and axon terminals of cerebellar Purkinje cells and basket cells have higher levels of parvalbumin immunoreactivity than somata and dendrites: quantitative analysis by immunogold labeling.

Authors:  T Kosaka; K Kosaka; T Nakayama; W Hunziker; C W Heizmann
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

View more
  39 in total

1.  Differential determinants for coupling of distinct G proteins with the class B secretin receptor.

Authors:  Gene L Garcia; Maoqing Dong; Laurence J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-25       Impact factor: 4.249

Review 2.  Brain meets body: the blood-brain barrier as an endocrine interface.

Authors:  William A Banks
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 3.  Secretin: Should we revisit its metabolic outcomes?

Authors:  D H St-Pierre; F Broglio
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

Review 4.  Emerging drugs for the treatment of symptoms associated with autism spectrum disorders.

Authors:  Logan K Wink; Martin H Plawecki; Craig A Erickson; Kimberly A Stigler; Christopher J McDougle
Journal:  Expert Opin Emerg Drugs       Date:  2010-09       Impact factor: 4.191

Review 5.  Distribution and Functional Implication of Secretin in Multiple Brain Regions.

Authors:  Ruanna Wang; Billy K C Chow; Li Zhang
Journal:  J Mol Neurosci       Date:  2018-06-07       Impact factor: 3.444

Review 6.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

7.  The knockout of secretin in cerebellar Purkinje cells impairs mouse motor coordination and motor learning.

Authors:  Li Zhang; Sookja Kim Chung; Billy Kwok Chong Chow
Journal:  Neuropsychopharmacology       Date:  2013-12-19       Impact factor: 7.853

8.  An indispensable role of secretin in mediating the osmoregulatory functions of angiotensin II.

Authors:  Vien H Y Lee; Leo T O Lee; Jessica Y S Chu; Ian P Y Lam; Francis K Y Siu; Hubert Vaudry; Billy K C Chow
Journal:  FASEB J       Date:  2010-08-25       Impact factor: 5.191

9.  A functional variable number of tandem repeats is located at the 5' flanking region of the human secretin gene plays a downregulatory role in expression.

Authors:  Leo T O Lee; Ian P Y Lam; Billy K C Chow
Journal:  J Mol Neurosci       Date:  2008-06-20       Impact factor: 3.444

10.  Distribution of secretin receptors in the rat central nervous system: an in situ hybridization study.

Authors:  Zsuzsanna E Tóth; Andrea Heinzlmann; Hitoshi Hashimoto; Katalin Köves
Journal:  J Mol Neurosci       Date:  2012-10-11       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.